{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:18:05Z","timestamp":1780485485529,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92057205"],"award-info":[{"award-number":["92057205"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32150710518"],"award-info":[{"award-number":["32150710518"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203511"],"award-info":[{"award-number":["82203511"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejmech.2025.117962","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T12:34:13Z","timestamp":1752582853000},"page":"117962","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Design, synthesis and biological evaluation of (E)-4-(2-((1H-indol-5-yl) methylene) hydrazineyl)-5,6,7,8-tetrahydropyrido [4\u2032,3\u2032:4,5] thieno[2,3-d] pyrimidine derivatives as Arf1-GEFs inhibitors for the treatment of colon cancer"],"prefix":"10.1016","volume":"297","author":[{"given":"Ning","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenfei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoliang","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengqi","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuetong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven X.","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117962_bib1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.bbamcr.2005.03.001","article-title":"Multiple activities for Arf1 at the Golgi complex","volume":"1744","author":"Donaldson","year":"2005","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.ejmech.2025.117962_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/bies.202200214","article-title":"The Arf family GTPases: regulation of vesicle biogenesis and beyond","volume":"45","author":"Li","year":"2023","journal-title":"Bioessays"},{"key":"10.1016\/j.ejmech.2025.117962_bib3","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nrm3117","article-title":"ARF family G proteins and their regulators: roles in membrane transport, development and disease","volume":"12","author":"Donaldson","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.117962_bib4","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1091\/mbc.E18-12-0820","article-title":"ARF GTPases and their GEFs and GAPs: concepts and challenges","volume":"30","author":"Sztul","year":"2019","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ejmech.2025.117962_bib5","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3892\/or.2017.5388","article-title":"Overexpression of ARF1 is associated with cell proliferation and migration through PI3K signal pathway in ovarian cancer","volume":"37","author":"Gu","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejmech.2025.117962_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fcell.2020.00217","article-title":"The role of ARF family proteins and their regulators and effectors in cancer progression: a therapeutic perspective","volume":"8","author":"Casalou","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejmech.2025.117962_bib7","doi-asserted-by":"crossref","first-page":"39834","DOI":"10.18632\/oncotarget.9405","article-title":"ARF1 promotes prostate tumorigenesis via targeting oncogenic MAPK signaling","volume":"7","author":"Davis","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2025.117962_bib8","doi-asserted-by":"crossref","first-page":"15811","DOI":"10.18632\/oncotarget.7515","article-title":"ADP-ribosylation factor 1 expression regulates epithelial-mesenchymal transition and predicts poor clinical outcome in triple-negative breast cancer","volume":"7","author":"Schlienger","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2025.117962_bib9","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1349-7006.2012.02243.x","article-title":"Overexpression of ADP-ribosylation factor 1 in human gastric carcinoma and its clinicopathological significance","volume":"103","author":"Tsai","year":"2012","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ejmech.2025.117962_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110958","article-title":"Disruption of the lipolysis pathway results in stem cell death through a sterile immunity-like pathway in adult Drosophila","volume":"39","author":"Aggarwal","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2025.117962_bib11","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41467-019-14046-9","article-title":"Arf1-mediated lipid metabolism sustains cancer cells and its ablation induces anti-tumor immune responses in mice","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.117962_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/lifemeta\/load036","article-title":"Blockade of Arf1-mediated lipid metabolism in cancers promotes tumor infiltration of cytotoxic T cells via the LPE-PPAR\u03b3-NF-\u03baB-CCL5 pathway","volume":"2","author":"Wang","year":"2023","journal-title":"Life Metabolism"},{"key":"10.1016\/j.ejmech.2025.117962_bib13","article-title":"Arf1 ablation in colorectal cancer cells activates a super signal complex in DC to enhance anti-tumor immunity","volume":"10","author":"Ma","year":"2023","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.ejmech.2025.117962_bib14","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S1097-2765(03)00475-1","article-title":"Crystal structure of ARF1\u2217Sec7 complexed with Brefeldin A and its implications for the guanine nucleotide exchange mechanism","volume":"12","author":"Mossessova","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2025.117962_bib15","doi-asserted-by":"crossref","first-page":"11805","DOI":"10.1074\/jbc.M600149200","article-title":"Dual specificity of the interfacial inhibitor brefeldin a for arf proteins and sec7 domains","volume":"281","author":"Zeeh","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117962_bib16","doi-asserted-by":"crossref","first-page":"11970","DOI":"10.1021\/acs.jmedchem.2c00532","article-title":"Design and characterization of a natural Arf-GEFs inhibitor prodrug CHNQD-01255 with potent anti-hepatocellular carcinoma efficacy in vivo","volume":"65","author":"Jiang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117962_bib17","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1074\/jbc.M111.316125","article-title":"AMF-26, a novel inhibitor of the Golgi system, targeting ADP-ribosylation factor 1 (Arf1) with potential for cancer therapy","volume":"287","author":"Ohashi","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117962_bib18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nchembio.144","article-title":"Golgicide A reveals essential roles for GBF1 in Golgi assembly and function","volume":"5","author":"S\u00e1enz","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.117962_bib19","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1039\/C0MB00035C","article-title":"Fine tuning Exo2, a small molecule inhibitor of secretion and retrograde trafficking pathways in mammalian cells","volume":"6","author":"Guetzoyan","year":"2010","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.ejmech.2025.117962_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100805","article-title":"Gbetagamma translocation to the Golgi apparatus activates ARF1 to spatiotemporally regulate G protein-coupled receptor signaling to MAPK","volume":"296","author":"Khater","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117962_bib21","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1111\/j.1600-0854.2010.01122.x","article-title":"LG186: an inhibitor of GBF1 function that causes Golgi disassembly in human and canine cells","volume":"11","author":"Boal","year":"2010","journal-title":"Traffic"},{"key":"10.1016\/j.ejmech.2025.117962_bib22","doi-asserted-by":"crossref","first-page":"8372","DOI":"10.1021\/ja202513s","article-title":"A homogeneous fluorescence resonance energy transfer system for monitoring the activation of a protein switch in real time","volume":"133","author":"Bill","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117962_bib23","article-title":"Novel Arf1 inhibitors drive cancer stem cell aging and potentiate anti-tumor immunity","volume":"11","author":"Wang","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.ejmech.2025.117962_bib24","doi-asserted-by":"crossref","first-page":"7896","DOI":"10.1021\/acs.jmedchem.2c00448","article-title":"Scaffold hopping strategy to identify prostanoid EP4 receptor antagonists for cancer immunotherapy","volume":"65","author":"Wang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117962_bib25","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1021\/acs.jmedchem.7b00267","article-title":"Structure-guided discovery of potent and selective inhibitors of ERK1\/2 from a modestly active and promiscuous chemical start point","volume":"60","author":"Ward","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117962_bib26","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.tetlet.2012.01.088","article-title":"Facile and regioselective synthesis of novel 2,4-disubstituted-5-fluoropyrimidines as potential kinase inhibitors","volume":"53","author":"Wada","year":"2012","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2025.117962_bib27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature19788","article-title":"The lipolysis pathway sustains normal and transformed stem cells in adult Drosophila","volume":"538","author":"Singh","year":"2016","journal-title":"Nature"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425007275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425007275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:58:27Z","timestamp":1776920307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425007275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":27,"alternative-id":["S0223523425007275"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117962","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of (E)-4-(2-((1H-indol-5-yl) methylene) hydrazineyl)-5,6,7,8-tetrahydropyrido [4\u2032,3\u2032:4,5] thieno[2,3-d] pyrimidine derivatives as Arf1-GEFs inhibitors for the treatment of colon cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117962","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117962"}}